文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2019 年冠状病毒病在墨西哥的生存情况:一项关于相关因素相互作用的队列研究。

Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors.

机构信息

Department of Clinical Research, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.

Centre for Research in Emerging Diseases, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.

出版信息

Front Public Health. 2021 Jul 27;9:660114. doi: 10.3389/fpubh.2021.660114. eCollection 2021.


DOI:10.3389/fpubh.2021.660114
PMID:34386471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8353107/
Abstract

The pandemic caused by the new coronavirus Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is currently affecting more than 200 countries. The most lethal clinical presentation is respiratory insufficiency, requiring attention in intensive care units (ICU). The most susceptible people are over 60 years old with comorbidities. The health systems organization may represent a transcendental role in survival. To analyze the correlation of sociodemographic factors, comorbidities and health system organization variables with survival in cases infected by SARS-CoV-2 during the first 7 months of the pandemic in Mexico. The cohort study was performed in a health system public basis from March 1st to September 30th, 2020. The included subjects were positive for the SARS-CoV-2 test, and the target variable was mortality in 60 days. The risk variables studied were: age, sex, geographic distribution, comorbidities, health system, hospitalization, and access to ICU. Bivariate statistics (-test), calculation of fatality rates, survival analyses and adjustment of confusing variables with Cox proportional-hazards were performed. A total of 753,090 subjects were analyzed, of which the 52% were men. There were 78,492 deaths (10.3% of general fatality and 43% inpatient). The variables associated with a higher risk of hospital mortality were age (from 60 years onwards), care in public sectors, geographic areas with higher numbers of infection and endotracheal intubation without management in the ICU. The variables associated with a lower survival in cases affected by SARS-CoV-2 were age, comorbidities, and respiratory insufficiency (with endotracheal intubation without care in the ICU). Additionally, an interaction was observed between the geographic location and health sector where they were treated.

摘要

由新型冠状病毒严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)引起的大流行目前正在影响 200 多个国家。最致命的临床表现是呼吸功能不全,需要在重症监护病房(ICU)中进行治疗。最易感染的人群是 60 岁以上合并有并发症的人群。卫生系统的组织可能在生存方面起着至关重要的作用。

为了分析社会人口统计学因素、合并症和卫生系统组织变量与墨西哥大流行期间前 7 个月感染 SARS-CoV-2 的病例的生存情况之间的相关性。

该队列研究是在 2020 年 3 月 1 日至 9 月 30 日期间在一个基于公共卫生系统的基础上进行的。纳入的研究对象是 SARS-CoV-2 检测呈阳性的患者,目标变量是 60 天内的死亡率。研究的风险变量有:年龄、性别、地理分布、合并症、卫生系统、住院和 ICU 入住。进行了单变量统计分析(-检验)、病死率计算、生存分析和 Cox 比例风险混杂变量调整。

共分析了 753090 名患者,其中 52%为男性。共有 78492 人死亡(一般病死率为 10.3%,住院患者病死率为 43%)。与住院死亡率较高相关的变量有年龄(60 岁以上)、在公共部门接受治疗、感染人数较多的地理区域以及在 ICU 中没有管理的气管插管。

与 SARS-CoV-2 感染病例生存情况较差相关的变量有年龄、合并症和呼吸功能不全(伴有气管插管但没有在 ICU 中进行治疗)。此外,还观察到地理位置和治疗所在的卫生部门之间存在交互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2c/8353107/c03285a5c83f/fpubh-09-660114-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2c/8353107/dfc543e0b4bc/fpubh-09-660114-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2c/8353107/c03285a5c83f/fpubh-09-660114-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2c/8353107/dfc543e0b4bc/fpubh-09-660114-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2c/8353107/c03285a5c83f/fpubh-09-660114-g0002.jpg

相似文献

[1]
Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors.

Front Public Health. 2021

[2]
Survival analysis and mortality predictors of COVID-19 in a pediatric cohort in Mexico.

Front Public Health. 2022

[3]
Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.

Am J Emerg Med. 2021-7

[4]
IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT.

Rev Invest Clin. 2020

[5]
Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.

Public Health. 2020-12

[6]
Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York.

JAMA Netw Open. 2020-9-1

[7]
Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.

J Clin Endocrinol Metab. 2020-8-1

[8]
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.

Trials. 2021-1-11

[9]
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.

Lancet Gastroenterol Hepatol. 2020-8-28

[10]
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.

Trials. 2020-10-28

引用本文的文献

[1]
Comorbidities and their association with COVID-19 mortality in Mexico between January 2020 and August 2021.

PLoS One. 2024

[2]
Spatial Survival Model for COVID-19 in México.

Healthcare (Basel). 2024-1-24

[3]
Risk Factors for Mortality of Hospitalized Adult Patients with COVID-19 Pneumonia: A Two-Year Cohort Study in a Private Tertiary Care Center in Mexico.

Int J Environ Res Public Health. 2023-3-2

[4]
Survival analysis and mortality predictors of COVID-19 in a pediatric cohort in Mexico.

Front Public Health. 2022

[5]
[Survival in pediatric patients with pneumonia in coronavirus disease 2019].

Rev Med Inst Mex Seguro Soc. 2022-8-31

本文引用的文献

[1]
[Epidemiology of COVID-19 in Mexico: from the 27th of February to the 30th of April 2020].

Rev Clin Esp. 2020-11

[2]
Factors associated with death in children with COVID-19 in Mexico.

Gac Med Mex. 2020

[3]
SARS-CoV-2 infection in children, clinical characteristics, diagnostic findings and therapeutic interventions at a tertiary care center in Riyadh, Saudi Arabia.

J Infect Public Health. 2021-4

[4]
Social inequalities and COVID-19 mortality in the city of São Paulo, Brazil.

Int J Epidemiol. 2021-7-9

[5]
Case fatality ratio of COVID-19 patients requiring invasive mechanical ventilation in Mexico: an analysis of nationwide data.

Crit Care. 2021-2-16

[6]
COVID-19 first anniversary review of cases, hospitalization, and mortality in the UK.

Expert Rev Respir Med. 2021-8

[7]
COVID-19 case fatality risk by age and gender in a high testing setting in Latin America: Chile, March-August 2020.

Infect Dis Poverty. 2021-2-3

[8]
Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data.

Lancet Respir Med. 2021-4

[9]
[Sex/gender differences in COVID-19 lethality: what the data say, and do not say].

Epidemiol Prev. 2020

[10]
Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission.

Ann Hepatol. 2021

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索